(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Topical OTC Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
The Future is Now: A Zero Contact Ultrasound

The Future is Now: A Zero Contact Ultrasound

by Jenn Porter | Feb 15, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Innovation, Medical Devices, Natural Health Products, Our View, Research/Science/Technology

Just over one week into the new decade and the medical device industry is already launching into the future. The innovative researchers at Massachusetts Institute of Technology (MIT) have taken a large step into the future of ultrasound imaging technologies. They have...
Update on Nitrosamine Impurities in Pharmaceutical Products

Update on Nitrosamine Impurities in Pharmaceutical Products

by Jenn Porter | Jan 7, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Natural Health Products, OTC Drugs, Research/Science/Technology, U.S. Regulatory

Health Canada has updated its assessment requirements for Nitrosamines in pharmaceutical products. Nitrosamines are, defined by the World Health Organization, as “any molecule containing the nitroso functional group. These molecules are of concern because nitrosamine...
European Commission Adopts Major Changes to Titanium Dioxide Classification

European Commission Adopts Major Changes to Titanium Dioxide Classification

by Jenn Porter | Nov 27, 2019 | Canadian Regulatory, Cosmetics, European Regulatory, Natural Health Products, Research/Science/Technology

Early last month the European Commission (EC) adopted the 14th adaptation to technical progress (ATP) of the Classification and Labelling (CLP) Regulation. Within this adaptation are 28 proposed changes to the harmonised classification and labelling of substances. One...

European Chemicals Agency (ECHA) Restricts Microplastics and Siloxanes

by Jenn Porter | Jul 9, 2019 | Cosmetics, European Regulatory, Medical Devices, Research/Science/Technology

Intentionally Added Microplastics: Microplastics are manufactured and used in many products on the European market. These ‘intentional’ uses of microplastics are the focus of the proposed restrictions. The potential posed environmental and human health risks of...

Can Sunscreen Absorption into the Bloodstream Pose Health Risks?

by Jenn Porter | May 9, 2019 | Canadian Regulatory, Cosmetics, European Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory

A pilot study recently published in the medical journal, JAMA, found that it took just one day of sunscreen use for several active ingredients in sunscreen products to enter the blood stream at high levels. The sunscreen absorption study, which was conducted by a...

Plastic Particles Are More Prevalent in Your Cosmetics & Personal Care Products Than You Think

by Jenn Porter | Jul 20, 2018 | Canadian Regulatory, Cosmetics, European Regulatory, Research/Science/Technology, U.S. Regulatory

Plastic microbeads are either banned or becoming banned in over 10 jurisdictions worldwide. However, this doesn’t mean that our cosmetics and personal care products are entirely plastic-free. There are many more plastic particles present that are in your everyday...
« Older Entries
Next Entries »

Recent Posts

  • MoCRA Updates
  • MoCRA Updates
  • Getting prepared for MoCRA by Dec. 29, 2023
  • Proposed Cosmetic Ingredient Updates
  • Cosmetics Animal Testing Ban

Recent Comments

    Archives

    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • January 2023
    • December 2022
    • November 2022
    • July 2022
    • June 2022
    • April 2022
    • March 2022
    • October 2021
    • July 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetics
    • Environment and Climate Change Canada
    • European Regulatory
    • Events/Company Updates
    • FDA
    • Importation of NHPs
    • Innovation
    • Medical Devices
    • MoCRA
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2023 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY
    ×

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     

    ×

    Jennifer Porter, BA Psychology, MBA – President & CEO

    Jennifer has been bringing new products to market for over 10 years. Her career with Focal Point Research has a foundation based on service excellence, leadership, and a passion for both the cosmetic and health products industries.

    With the successful development of hundreds of new products, Jennifer was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

    Jennifer balances her career by honouring her wanderlust and adopting rescue dogs along the way.

    ×

    Robert Fichtner

    Since co-founding Focal Point over 20 years ago, Rob has led our Regulatory and Scientific practice. A chemist by training, his experience includes Cosmetics, Drugs, Medical Devices, Consumer Products and Natural Health Products (Dietary Supplements). Rob has participated in the launch of thousands of products including their formulation, manufacturing and regulatory submissions for approval. His wealth of experience spans almost 40 years in innovation.
    Rob has been involved in all aspects of innovation and new product development. He shares some of his insights in his new video series “Lectures in Innovation”. You can view the first video here.
    When not supporting innovators, Rob spends his time becoming a better sailor and guitar player.